Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.

Bezrookove V, Nosrati M, Miller JR 3rd, De Semir D, Dar AA, Vosoughi E, Vaquero E, Sucker A, Lazar AJ, Gershenwald JE, Davies MA, Schadendorf D, Kashani-Sabet M.

Clin Cancer Res. 2018 Sep 1;24(17):4119-4125. doi: 10.1158/1078-0432.CCR-18-0791. Epub 2018 May 18.

PMID:
29776954
2.

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies.

Vosoughi E, Lee JM, Miller JR, Nosrati M, Minor DR, Abendroth R, Lee JW, Andrews BT, Leng LZ, Wu M, Leong SP, Kashani-Sabet M, Kim KB.

BMC Cancer. 2018 Apr 27;18(1):490. doi: 10.1186/s12885-018-4374-x.

3.

Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis.

Goyonlo VM, Vosoughi E, Kiafar B, Nahidi Y, Momenzadeh A, Taheri AR.

Indian J Dermatol. 2014 Nov;59(6):631. doi: 10.4103/0019-5154.143571.

Supplemental Content

Loading ...
Support Center